KIDNEY TRANSPLANT REJECTION
Clinical trials for KIDNEY TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to save transplanted kidneys from rejection
Disease control Not yet recruitingThis study is testing whether adding two new drugs, carfilzomib and belatacept, to the standard anti-rejection medications can better control a specific type of kidney transplant rejection. It will involve about 25 kidney transplant patients whose bodies are making harmful antibo…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
AI steps in to protect transplanted kidneys
Disease control Not yet recruitingThis pilot study is testing whether a computer system using artificial intelligence (AI) can help doctors find the best doses of anti-rejection drugs for people who have received a kidney transplant. The goal is to protect the new kidney from damage while using the lowest effecti…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New blood tests aim to spot early transplant trouble
Disease control Not yet recruitingThis study is testing two blood tests (TruGraf and TRAC) to see if they can help doctors better monitor kidney transplant patients. The tests look for early signs of organ rejection so doctors can adjust anti-rejection medications sooner. The study will follow 600 kidney transpla…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Transplant Genomics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo aims to stop silent kidney transplant failure before it starts
Disease control Not yet recruitingThis study is testing whether switching kidney transplant patients from standard anti-rejection drugs to a newer drug called belatacept can better control early, silent rejection. Researchers will enroll 290 adult kidney transplant recipients who develop certain antibodies but sh…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Stem cell trial for failing kidney transplants halted after safety issues
Disease control Not yet recruitingThis study tested whether a patient's own bone marrow stem cells could help control chronic rejection in kidney transplant patients. It involved a very small group of patients who received the stem cell infusion after their standard anti-rejection treatment. The trial was stopped…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: NA • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC